MAGL-IN-6

• UNSPSC Description:

  MAGL-IN-6 is a potent MAGL inhibitor with an IC50 of 4.71 nM. MAGL-IN-6 can be used for neurological disorders research (WO2020065613A1; example 234)[1].

• Target Antigen:

  MAGL

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/magl-in-6.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CN1C(C2=CC(F)=C(C(F)=C2)F)=C3C([C@@H](N(CC3)C(C4=CC5=C(N=CC=C5)C=C4)=O)C)=N1

• Molecular Weight:

  436.43

• References & Citations:

  [1]Michael K. Ameriks, et al. Monoacylglycerol lipase modulators. WO2020065613A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2414320-29-7